An Exploratory Clinical Study of SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment
Latest Information Update: 03 Jul 2024
At a glance
- Drugs Adebrelimab (Primary) ; SHR-A1921 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Jul 2024 New trial record